Scott R Brodeur

Title: Scott R Brodeur: Innovator in Antigen Binding Domains

Introduction

Scott R Brodeur is a notable inventor based in New Hope, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of proteins that interact with the CD3 antigen. With a total of two patents to his name, Brodeur's work is paving the way for advancements in therapeutic applications.

Latest Patents

Scott R Brodeur's latest patents focus on proteins comprising CD3 antigen binding domains and their uses. The disclosures provide antigen binding domains that specifically bind to the cluster of differentiation 3 (CD3) protein. This includes the antigen binding domains that target CD3ε, along with polynucleotides encoding these domains, vectors, host cells, and methods for their production and application.

Career Highlights

Brodeur is currently associated with Janssen Biotech, Inc., where he continues to innovate in the field of biotechnology. His work is instrumental in developing new therapeutic strategies that leverage the immune system's capabilities.

Collaborations

Some of his notable coworkers include Adam Zwolak and Rajkumar Ganesan, who contribute to the collaborative efforts in research and development at Janssen Biotech, Inc.

Conclusion

Scott R Brodeur's contributions to the field of antigen binding domains highlight his role as an influential inventor in biotechnology. His patents and ongoing work at Janssen Biotech, Inc. are set to make a significant impact in therapeutic innovations.